title: How to remove the CoreValve aortic bioprosthesis in a case of surgical aortic valve replacement.
abstract: Transcatheter aortic valve implantation has been introduced as a treatment modality applied to high-risk surgery patients with severe symptomatic aortic stenosis, and it has been demonstrated to be an efficient and safe treatment option. Litzler and colleagues reported a case of a bailout of a transcatheter aortic valve implantation because of severe paravalvular leaks, using a 23-mm Edwards-SAPIEN Valve (Edwards Lifesciences, Irvine, CA), with conversion to conventional surgical aortic valve replacement. The authors reported an easy valve removal despite the impaction of the stent in the cusps of the native valve. Thyregod and colleagues reported a surgical valve replacement in a patient with a dysfunctional CoreValve self-expanding aortic valve bioprosthesis 4 months after implantation.
authors.affiliation: Department of Cardiology and Cardiac Surgery, Niguarda Ca' Granda Hospital, Milan, Italy. giuseppe.bruschi@fastwebnet.it
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Bruschi
authors.forename: Jacopo
authors.initials: J
authors.lastname: Oreglia
authors.forename: Federico
authors.initials: F
authors.lastname: De Marco
authors.forename: Paola
authors.initials: P
authors.lastname: Colombo
authors.forename: Michele
authors.initials: M
authors.lastname: Mondino
authors.forename: Roberto
authors.initials: R
authors.lastname: Paino
authors.forename: Silvio
authors.initials: S
authors.lastname: Klugmann
authors.forename: Luigi
authors.initials: L
authors.lastname: Martinelli
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis; D020878:Device Removal / Q000379:methods*; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis; D006801:Humans; D011474:Prosthesis Design; D012086:Reoperation / Q000379:methods*